UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7680) 7680
Newspaper Article (457) 457
Book Chapter (40) 40
Magazine Article (31) 31
Newsletter (24) 24
Book / eBook (7) 7
Trade Publication Article (5) 5
Publication (4) 4
Reference (4) 4
Transcript (4) 4
Web Resource (3) 3
Conference Proceeding (2) 2
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (6514) 6514
humans (6390) 6390
life sciences & biomedicine (6241) 6241
oncology (3427) 3427
male (2891) 2891
female (2888) 2888
middle aged (2206) 2206
imatinib mesylate (1962) 1962
adult (1959) 1959
antineoplastic agents - administration & dosage (1905) 1905
cancer (1807) 1807
aged (1757) 1757
animals (1636) 1636
hematology (1635) 1635
pyrimidines - administration & dosage (1587) 1587
benzamides (1565) 1565
treatment outcome (1542) 1542
biological and medical sciences (1539) 1539
medical sciences (1510) 1510
dose-response relationship, drug (1428) 1428
drug dosages (1414) 1414
tumors (1401) 1401
piperazines - administration & dosage (1332) 1332
research (1325) 1325
pharmacology & pharmacy (1296) 1296
chemotherapy (1291) 1291
care and treatment (1282) 1282
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (1223) 1223
antineoplastic agents (1206) 1206
antineoplastic agents - therapeutic use (1159) 1159
dosage and administration (1126) 1126
drug therapy (1110) 1110
leukemia (1099) 1099
antineoplastic combined chemotherapy protocols - therapeutic use (947) 947
protein kinase inhibitors - administration & dosage (944) 944
chronic myeloid leukemia (926) 926
imatinib (887) 887
cell line, tumor (829) 829
medicine & public health (812) 812
mice (808) 808
antimitotic agents (804) 804
cancer therapies (793) 793
antineoplastic agents - adverse effects (792) 792
pyrimidines - therapeutic use (788) 788
patients (781) 781
kinases (774) 774
health aspects (761) 761
analysis (749) 749
clinical trials (717) 717
antineoplastic agents - pharmacology (712) 712
mutation (705) 705
protein kinase inhibitors - therapeutic use (685) 685
aged, 80 and over (666) 666
neoplasms - drug therapy (665) 665
piperazines - therapeutic use (652) 652
apoptosis (635) 635
adolescent (630) 630
hematologic and hematopoietic diseases (622) 622
pharmacology. drug treatments (608) 608
abridged index medicus (586) 586
tyrosine (580) 580
young adult (557) 557
metastasis (548) 548
pyrimidines - adverse effects (547) 547
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (545) 545
cell proliferation - drug effects (537) 537
apoptosis - drug effects (535) 535
proteins (532) 532
pyrimidines - pharmacology (530) 530
disease-free survival (529) 529
studies (512) 512
prognosis (495) 495
dasatinib (489) 489
hemic and lymphatic diseases (483) 483
protein kinase inhibitors - pharmacology (473) 473
protein-tyrosine kinases - antagonists & inhibitors (472) 472
drug administration schedule (471) 471
hematology, oncology and palliative medicine (450) 450
time factors (449) 449
protein kinase inhibitors - adverse effects (443) 443
drug resistance, neoplasm (441) 441
genetic aspects (438) 438
medicine (438) 438
risk factors (438) 438
leukemia, myelogenous, chronic, bcr-abl positive - genetics (432) 432
complications and side effects (422) 422
piperazines - pharmacology (418) 418
piperazines - adverse effects (414) 414
retrospective studies (414) 414
pharmacology/toxicology (408) 408
leukemia, myelogenous, chronic, bcr-abl positive - pathology (403) 403
research article (394) 394
medical research (392) 392
follow-up studies (387) 387
administration, oral (385) 385
fusion proteins, bcr-abl - genetics (379) 379
drug resistance (376) 376
drugs (376) 376
signal transduction - drug effects (375) 375
antineoplastic combined chemotherapy protocols - administration & dosage (373) 373
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8174) 8174
German (44) 44
Japanese (33) 33
French (30) 30
Russian (22) 22
Chinese (11) 11
Spanish (8) 8
Polish (7) 7
Portuguese (7) 7
Hungarian (6) 6
Italian (4) 4
Danish (3) 3
Dutch (3) 3
Swedish (2) 2
Turkish (2) 2
Czech (1) 1
Korean (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2012, Volume 307, Issue 12, pp. 1265 - 1272
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | General aspects | Medical sciences | Tumors | Piperazines - administration & dosage | Gastrointestinal Neoplasms - genetics | Gastrointestinal Neoplasms - drug therapy | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Young Adult | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Chemotherapy, Adjuvant | Gastrointestinal Stromal Tumors - genetics | Gastrointestinal Stromal Tumors - surgery | Drug Administration Schedule | Neoplasm Recurrence, Local - prevention & control | Pyrimidines - administration & dosage | Gastrointestinal Neoplasms - surgery | Treatment Outcome | Imatinib Mesylate | Piperazines - adverse effects | Gastrointestinal Stromal Tumors - drug therapy | Receptor, Platelet-Derived Growth Factor alpha - genetics | Pyrimidines - adverse effects | Survival Analysis | Aged | Benzamides | Clinical trials | Postoperative period | Drug therapy | Digestive system | Pathology | tumors | Hospitals | Reviews | Safety engineering | survival | Mutation | intervention | surgery | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 11, pp. 1029 - 1035
Journal Article
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 31, pp. 5175 - 5181
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 12, pp. 1175 - 1182
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2006, Volume 354, Issue 24, pp. 2531 - 2541
Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 24, pp. 2251 - 2259
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Blast Crisis - prevention & control | Protein Kinase Inhibitors - adverse effects | Young Adult | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Pyrimidines - administration & dosage | Leukemia, Myeloid, Chronic-Phase - drug therapy | Kaplan-Meier Estimate | Piperazines - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Adolescent | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Aged | Benzamides | Nilotinib | Antiviral agents | Safety and security measures | Chronic myeloid leukemia | Drug therapy | Comparative analysis | Clinical trials | Drug dosages | Medical treatment | Index Medicus | Abridged Index Medicus | bcr-abl | pathology | Leukemia | Chronic-Phase | Myeloid | Klinisk medicin | 80 and over | Pyrimidines | administration & dosage | Fusion Proteins | Blast Crisis | drug therapy | Piperazines | Antineoplastic Agents | prevention & control | antagonists & inhibitors | Clinical Medicine | Protein Kinase Inhibitors | adverse effects | therapeutic use
Journal Article